[1] Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol,1992,27:383-389.
[2] Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science,2002,297:565-569.
[3] Bell JF, Sharpless NE. Telomeres, p21 and the cancer-aging hypothesis. Nat Genet, 2007,39:11-12.
[4] Nault JC, Ningarhari M, Rebouissou S, et al. The role of telomeres and telomerase in cirrhosis and liver cancer. Nat Rev Gastroenterol Hepatol,2019,16:544-558.
[5] Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genet,2011,204:635-645.
[6] Munroe M, Niero EL, Fok WC, et al. Telomere Dysfunction Activates p53 and Represses HNF4α Expression Leading to Impaired Human Hepatocyte Development and Function. Hepatology,2020,72:1412-1429.
[7] Hoare M, Das T, Alexander G. Ageing, telomeres, senescence, and liver injury. J Hepatol, 2010,53:950-961. |
